The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration

•A tulobuterol patch containing a β2-adrenergic agonist at two different doses was investigated.•The pharmacokinetics of tulobuterol was evaluated in dogs after intravenous and transdermal administration.•A therapeutic blood concentration was reached with both transdermal doses.•The tulobuterol patc...

Full description

Saved in:
Bibliographic Details
Published in:The veterinary journal (1997) Vol. 208; pp. 90 - 92
Main Authors: Kim, J.H., Kim, T.H., Park, H.J., Choi, Y.J., Kang, J.H., Song, K.H., Koo, T.S., Seo, K.W.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-02-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract •A tulobuterol patch containing a β2-adrenergic agonist at two different doses was investigated.•The pharmacokinetics of tulobuterol was evaluated in dogs after intravenous and transdermal administration.•A therapeutic blood concentration was reached with both transdermal doses.•The tulobuterol patch can be safely and effectively used in dogs. Tulobuterol is a β2-adrenergic agonist that was the first bronchodilator approved as a transdermal patch for humans. Previous studies have examined the pharmacokinetics of tulobuterol in humans but not in the veterinary species. In this study, the pharmacokinetics of tulobuterol was examined in healthy Beagle dogs after transdermal and intravenous administration. The Cmax was 2.09 ng/mL at 16.0 h for a 0.2 mg/kg patch and 4.85 ng/mL at 13.6 h for a 0.4 mg/kg patch. The effective blood level in humans is 1–3 ng/mL, a concentration achieved using the 0.2 mg/kg patch in dogs. In conclusion, application of a 0.2 mg/kg tulobuterol patch to healthy dogs led to an apparently effective blood concentration for 24 h.
AbstractList Tulobuterol is a β2-adrenergic agonist that was the first bronchodilator approved as a transdermal patch for humans. Previous studies have examined the pharmacokinetics of tulobuterol in humans but not in the veterinary species. In this study, the pharmacokinetics of tulobuterol was examined in healthy Beagle dogs after transdermal and intravenous administration. The Cmax was 2.09 ng/mL at 16.0 h for a 0.2 mg/kg patch and 4.85 ng/mL at 13.6 h for a 0.4 mg/kg patch. The effective blood level in humans is 1-3 ng/mL, a concentration achieved using the 0.2 mg/kg patch in dogs. In conclusion, application of a 0.2 mg/kg tulobuterol patch to healthy dogs led to an apparently effective blood concentration for 24 h.
•A tulobuterol patch containing a β2-adrenergic agonist at two different doses was investigated.•The pharmacokinetics of tulobuterol was evaluated in dogs after intravenous and transdermal administration.•A therapeutic blood concentration was reached with both transdermal doses.•The tulobuterol patch can be safely and effectively used in dogs. Tulobuterol is a β2-adrenergic agonist that was the first bronchodilator approved as a transdermal patch for humans. Previous studies have examined the pharmacokinetics of tulobuterol in humans but not in the veterinary species. In this study, the pharmacokinetics of tulobuterol was examined in healthy Beagle dogs after transdermal and intravenous administration. The Cmax was 2.09 ng/mL at 16.0 h for a 0.2 mg/kg patch and 4.85 ng/mL at 13.6 h for a 0.4 mg/kg patch. The effective blood level in humans is 1–3 ng/mL, a concentration achieved using the 0.2 mg/kg patch in dogs. In conclusion, application of a 0.2 mg/kg tulobuterol patch to healthy dogs led to an apparently effective blood concentration for 24 h.
Author Kang, J.H.
Park, H.J.
Kim, J.H.
Koo, T.S.
Choi, Y.J.
Song, K.H.
Kim, T.H.
Seo, K.W.
Author_xml – sequence: 1
  givenname: J.H.
  surname: Kim
  fullname: Kim, J.H.
  organization: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, 99 Daehakro, Daejeon, South Korea
– sequence: 2
  givenname: T.H.
  orcidid: 0000-0003-3237-0244
  surname: Kim
  fullname: Kim, T.H.
  organization: Graduate School of New Drug Discovery and Development, Chungnam National University, 99 Daehakro, Daejeon, South Korea
– sequence: 3
  givenname: H.J.
  surname: Park
  fullname: Park, H.J.
  organization: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, 99 Daehakro, Daejeon, South Korea
– sequence: 4
  givenname: Y.J.
  surname: Choi
  fullname: Choi, Y.J.
  organization: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, 99 Daehakro, Daejeon, South Korea
– sequence: 5
  givenname: J.H.
  surname: Kang
  fullname: Kang, J.H.
  organization: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju 362-763, South Korea
– sequence: 6
  givenname: K.H.
  surname: Song
  fullname: Song, K.H.
  organization: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, 99 Daehakro, Daejeon, South Korea
– sequence: 7
  givenname: T.S.
  surname: Koo
  fullname: Koo, T.S.
  email: kootae@cnu.ac.kr
  organization: Graduate School of New Drug Discovery and Development, Chungnam National University, 99 Daehakro, Daejeon, South Korea
– sequence: 8
  givenname: K.W.
  surname: Seo
  fullname: Seo, K.W.
  email: kwseo@cnu.ac.kr
  organization: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, 99 Daehakro, Daejeon, South Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26639828$$D View this record in MEDLINE/PubMed
BookMark eNp9kM1u1DAURi3UirYDL8ACecmimfqncRKJDVQUKlXqZvaWY19PPTj2YDtT8QI8EA_CM9XRFJasrv3pu0f2uUAnIQZA6B0la0qouNqty2Hn14zQtgZrQtkrdE5bzho2dPSknslAGsI4P0MXOe8IIcP1NXuNzpgQfOhZf45-bR4B7x9VmpSO312A4nTG0eJS8z-_WaNMghA17EtMWG1jcLlc4jL7OM4FUvSX2AX8GdTWAzZxm7GN3scnF7a4JBWygcr2WAVTizU5VNycsTKTW1hJFRfDG3Rqlc_w9mWu0Ob2y-bmW3P_8PXu5tN9oxljpRlVa8So2MB6TlWneDv2IPp67dSgu9bYTljRGyag7ceOj9ZyTtqhTjuA4Sv04Yjdp_hjhlzk5LIG71WA-ihJOyGqm77qWSF2rOoUc05g5T65SaWfkhK56Jc7ueiXi_4lq_rr0vsX_jxOYP6t_PVdCx-PBaifPDhIMmsHQYNxCXSRJrr_8Z8BQOGczA
Cites_doi 10.2332/allergolint.08-OA-0060
10.1620/tjem.212.309
10.1007/BF00316473
10.2332/allergolint.54.283
10.1016/0007-0971(77)90086-9
10.1159/000195176
ContentType Journal Article
Copyright 2015 Elsevier Ltd
Copyright © 2015 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2015 Elsevier Ltd
– notice: Copyright © 2015 Elsevier Ltd. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.tvjl.2015.10.012
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Veterinary Medicine
EISSN 1532-2971
EndPage 92
ExternalDocumentID 10_1016_j_tvjl_2015_10_012
26639828
S1090023315004098
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
123
1B1
1RT
1~.
1~5
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
AABNK
AABVA
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALCJ
AALRI
AAOAW
AAQFI
AAQXK
AATLK
AAXUO
ABBQC
ABFNM
ABGRD
ABJNI
ABKYH
ABLVK
ABMAC
ABMZM
ABRWV
ABXDB
ABYKQ
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
ADMUD
ADQTV
AEBSH
AEKER
AENEX
AEQOU
AESVU
AEXOQ
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
CBWCG
COF
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
K-O
KOM
LCYCR
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
QYZTP
R2-
RIG
ROL
RPZ
SDF
SDG
SES
SEW
SNL
SPCBC
SSA
SSH
SSZ
T5K
UHS
~G-
~KM
AAHBH
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c222t-ba5d6ba292831a7a35b8e689287a9c75df76f68d26e58b73bff33059bfff9ed3
ISSN 1090-0233
IngestDate Sun Sep 29 08:48:32 EDT 2024
Thu Sep 26 16:38:50 EDT 2024
Sat Sep 28 07:57:42 EDT 2024
Fri Feb 23 02:18:44 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Pharmacokinetics
Transdermal patch
β2-adrenoceptor agonist
Canine
Tulobuterol
β-adrenoceptor agonist
Language English
License Copyright © 2015 Elsevier Ltd. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c222t-ba5d6ba292831a7a35b8e689287a9c75df76f68d26e58b73bff33059bfff9ed3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3237-0244
PMID 26639828
PQID 1766266866
PQPubID 23479
PageCount 3
ParticipantIDs proquest_miscellaneous_1766266866
crossref_primary_10_1016_j_tvjl_2015_10_012
pubmed_primary_26639828
elsevier_sciencedirect_doi_10_1016_j_tvjl_2015_10_012
PublicationCentury 2000
PublicationDate February 2016
2016-Feb
2016-02-00
20160201
PublicationDateYYYYMMDD 2016-02-01
PublicationDate_xml – month: 02
  year: 2016
  text: February 2016
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle The veterinary journal (1997)
PublicationTitleAlternate Vet J
PublicationYear 2016
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Yamaguchi, Nagata, Miyazawa (bib0050) 2005; 54
Hozawa, Haruta, Terada, Yamakido (bib0015) 2009; 58
Uematsu, Nakano, Kosuge, Kanamaru, Nakashima (bib0045) 1993; 44
Nakano, Horiuchi, Fujiwara, Unozawa (bib0025) 1996
Matthys, Daikeler, Krauss, Vastag (bib0020) 1987; 51
Shindoh, Tsushima, Shindoh, Tamura (bib0030) 2007; 212
Tomohiro, Hisatoshi (bib0035) 2013; 2
Turner-Warwick (bib0040) 1977; 71
Matthys (10.1016/j.tvjl.2015.10.012_bib0020) 1987; 51
Nakano (10.1016/j.tvjl.2015.10.012_bib0025) 1996
Shindoh (10.1016/j.tvjl.2015.10.012_bib0030) 2007; 212
Yamaguchi (10.1016/j.tvjl.2015.10.012_bib0050) 2005; 54
Tomohiro (10.1016/j.tvjl.2015.10.012_bib0035) 2013; 2
Hozawa (10.1016/j.tvjl.2015.10.012_bib0015) 2009; 58
Turner-Warwick (10.1016/j.tvjl.2015.10.012_bib0040) 1977; 71
Uematsu (10.1016/j.tvjl.2015.10.012_bib0045) 1993; 44
References_xml – volume: 2
  start-page: 9
  year: 2013
  end-page: 18
  ident: bib0035
  article-title: Long-term safety, efficacy, and patient acceptability of the tulobuterol patch
  publication-title: Research and Reports in Transdermal Drug Delivery
  contributor:
    fullname: Hisatoshi
– volume: 58
  start-page: 509
  year: 2009
  end-page: 518
  ident: bib0015
  article-title: Effects of the addition of β
  publication-title: Allergology International
  contributor:
    fullname: Yamakido
– volume: 54
  start-page: 283
  year: 2005
  end-page: 288
  ident: bib0050
  article-title: Tulobuterol, a β
  publication-title: Allergology International
  contributor:
    fullname: Miyazawa
– volume: 71
  start-page: 73
  year: 1977
  end-page: 86
  ident: bib0040
  article-title: On observing patterns of airflow obstruction in chronic asthma
  publication-title: British Journal of Diseases of the Chest
  contributor:
    fullname: Turner-Warwick
– volume: 44
  start-page: 361
  year: 1993
  end-page: 364
  ident: bib0045
  article-title: The pharmacokinetics of the β2-adrenoceptor, tulobuterol, given transdermally and by inhalation
  publication-title: European Journal of Clinical Pharmacology
  contributor:
    fullname: Nakashima
– volume: 51
  start-page: 105
  year: 1987
  end-page: 112
  ident: bib0020
  article-title: Action of tulobuterol and fenoterol on the mucociliary clearance
  publication-title: Respiration; International Review of Thoracic Diseases
  contributor:
    fullname: Vastag
– year: 1996
  ident: bib0025
  article-title: Percutaneous preparation of tulobuterol
  contributor:
    fullname: Unozawa
– volume: 212
  start-page: 309
  year: 2007
  end-page: 317
  ident: bib0030
  article-title: Transdermal treatment with tulobuterol increases isometric contractile properties of diaphragm muscle in mice
  publication-title: The Tohoku Journal of Experimental Medicine
  contributor:
    fullname: Tamura
– volume: 2
  start-page: 9
  year: 2013
  ident: 10.1016/j.tvjl.2015.10.012_bib0035
  article-title: Long-term safety, efficacy, and patient acceptability of the tulobuterol patch
  publication-title: Research and Reports in Transdermal Drug Delivery
  contributor:
    fullname: Tomohiro
– volume: 58
  start-page: 509
  year: 2009
  ident: 10.1016/j.tvjl.2015.10.012_bib0015
  article-title: Effects of the addition of β2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma
  publication-title: Allergology International
  doi: 10.2332/allergolint.08-OA-0060
  contributor:
    fullname: Hozawa
– year: 1996
  ident: 10.1016/j.tvjl.2015.10.012_bib0025
  contributor:
    fullname: Nakano
– volume: 212
  start-page: 309
  year: 2007
  ident: 10.1016/j.tvjl.2015.10.012_bib0030
  article-title: Transdermal treatment with tulobuterol increases isometric contractile properties of diaphragm muscle in mice
  publication-title: The Tohoku Journal of Experimental Medicine
  doi: 10.1620/tjem.212.309
  contributor:
    fullname: Shindoh
– volume: 44
  start-page: 361
  year: 1993
  ident: 10.1016/j.tvjl.2015.10.012_bib0045
  article-title: The pharmacokinetics of the β2-adrenoceptor, tulobuterol, given transdermally and by inhalation
  publication-title: European Journal of Clinical Pharmacology
  doi: 10.1007/BF00316473
  contributor:
    fullname: Uematsu
– volume: 54
  start-page: 283
  year: 2005
  ident: 10.1016/j.tvjl.2015.10.012_bib0050
  article-title: Tulobuterol, a β2-agonist, attenuates eosinophil adhesion to endothelial cells
  publication-title: Allergology International
  doi: 10.2332/allergolint.54.283
  contributor:
    fullname: Yamaguchi
– volume: 71
  start-page: 73
  year: 1977
  ident: 10.1016/j.tvjl.2015.10.012_bib0040
  article-title: On observing patterns of airflow obstruction in chronic asthma
  publication-title: British Journal of Diseases of the Chest
  doi: 10.1016/0007-0971(77)90086-9
  contributor:
    fullname: Turner-Warwick
– volume: 51
  start-page: 105
  year: 1987
  ident: 10.1016/j.tvjl.2015.10.012_bib0020
  article-title: Action of tulobuterol and fenoterol on the mucociliary clearance
  publication-title: Respiration; International Review of Thoracic Diseases
  doi: 10.1159/000195176
  contributor:
    fullname: Matthys
SSID ssj0009442
Score 2.1603096
Snippet •A tulobuterol patch containing a β2-adrenergic agonist at two different doses was investigated.•The pharmacokinetics of tulobuterol was evaluated in dogs...
Tulobuterol is a β2-adrenergic agonist that was the first bronchodilator approved as a transdermal patch for humans. Previous studies have examined the...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 90
SubjectTerms Administration, Cutaneous
Administration, Intravenous - veterinary
Adrenergic beta-2 Receptor Agonists - blood
Adrenergic beta-2 Receptor Agonists - pharmacokinetics
Animals
Bronchodilator Agents - blood
Bronchodilator Agents - pharmacokinetics
Canine
Dogs - metabolism
Pharmacokinetics
Random Allocation
Terbutaline - analogs & derivatives
Terbutaline - blood
Terbutaline - pharmacokinetics
Transdermal patch
Tulobuterol
β2-adrenoceptor agonist
Title The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration
URI https://dx.doi.org/10.1016/j.tvjl.2015.10.012
https://www.ncbi.nlm.nih.gov/pubmed/26639828
https://search.proquest.com/docview/1766266866
Volume 208
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dbtMwFLa67oYbBOOv_MlI7GpLlCZNbF9uJahUAiGtQuMqchK7rFTJxNLxBjwQD8IzcU5tp2nRECBxk7ZHbWL5-3p8bB9_h5CXMEiWIoi5FzDNvVHISk-EgfSKgLOoiIogKXCiODlj7875q3SU9nquOt7G9l-RBhtgjSdn_wLt9qZggPeAOVwBdbj-Me6XVo_6M4SQaxlmmwhwOE4PT2FaKPH4do0JLZhCOa9RPRf7ulkt6xxrPJiyWxfV0amSczxaVc9Rt2G5rL_auhLVVYk-fWnVmxqsYrRWe5Vbarzd2Bdbdo3ZN-YIsNOsQKUoIbpLErbC89Sf-DumWcf03mZ5T_xpaxt_qtfZCR-dza5nDNsUaLfI5g7abLKa0C8HIoAvGs0MXzlfHXqhMBVcnDMPA95xx6YSqR3YTc29X4YMs3qx8JvrBW5FDWMfs_1sbve2FPcZNgNbAVE0OD_B98h-CA4u7pP9kzfp-XQj9zwamX1222x7XMtkFu4-6aaQ6KYpzzr0md0ht-2chZ4Yst0lPVUdkIMPLZT0rU3QuEe-Ach0l3601hToR39836YetdQ7ph3iHdOLihraUaQdbWlHO7SjQDvaoR3dpt19MnudzsYTz5b68AoIUBsvl3GZ5DIUEO0OJZNRnHOVcPjIpChYXGqW6ISXYaJinrMo1zqCkUrAqxaqjB6QflVX6hGhpVAwbgVahxB4KQ7hd6CYBEAgRCuY0ANy5Do7uzSCLpnLdFxkCE2G0KANoBmQ2OGR2ZDUhJoZ0Oe3v3vhwMvAX-MmnKwUdEeGgqwQFPMkGZCHBtW2HWCPBA_543986hNya_OPekr6zZeVekb2rsrVc0vQn4T5wwk
link.rule.ids 315,782,786,27935,27936
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+pharmacokinetics+of+the+%CE%B22-adrenoceptor+agonist%2C+tulobuterol%2C+in+Beagle+dogs+following+transdermal+and+intravenous+administration&rft.jtitle=The+veterinary+journal+%281997%29&rft.au=Kim%2C+J.H.&rft.au=Kim%2C+T.H.&rft.au=Park%2C+H.J.&rft.au=Choi%2C+Y.J.&rft.date=2016-02-01&rft.pub=Elsevier+Ltd&rft.issn=1090-0233&rft.eissn=1532-2971&rft.volume=208&rft.spage=90&rft.epage=92&rft_id=info:doi/10.1016%2Fj.tvjl.2015.10.012&rft.externalDocID=S1090023315004098
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1090-0233&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1090-0233&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1090-0233&client=summon